MedVital, a next-generation healthcare startup focused on wound care and minimally invasive aesthetics, has secured ₹8.4 crore in pre-seed funding to address critical gaps in India's skin restoration and regenerative medicine landscape. The investment round was led by Nihar Parikh's 4point0 Health Ventures, with participation from prominent operator-investors including founders from Tata 1mg, NephroPlus, SafeExpress, Eye Q Hospital, Hexa Health, and AstroTalk.
Founded in 2023 by Dr. Varun Gupta and Tarun Bansal, MedVital aims to transform how complex wounds are treated in a country facing mounting healthcare challenges from chronic wounds driven by diabetes, aging, obesity, and trauma.
Innovative Approach to Wound Management
At the core of MedVital's innovation is NoWound™, India's first locally manufactured Negative Pressure Wound Therapy (NPWT) device designed for controlled healing of complex wounds. The device distinguishes itself from legacy NPWT systems with its compact form factor and digital integration capabilities, making it suitable for deployment even in low-resource environments.
"We are building a full-stack platform that integrates clinically proven devices, intelligent monitoring, and next-generation biomaterials to transform how complex wounds are treated and how patients recover," said Dr. Varun Gupta, Co-Founder and CEO of MedVital. "Our mission is simple: to make advanced solutions accessible and fairly priced for everyone."
The company's approach combines intelligent monitoring systems with next-gen biomaterials, creating an integrated platform for wound care that can be deployed across various healthcare settings—from intensive care units to rural clinics and homes.
Strategic Expansion Plans
The newly secured funding will enable MedVital to scale operations, diversify its product portfolio, and extend its distribution network. The company plans to strengthen its supply chain infrastructure to meet growing demand while expanding access to advanced wound care solutions across tertiary hospitals, rural clinics, and home-care centers.
"Our vision is to make India a global hub for cutting-edge wound care and skin restoration solutions," said Tarun Bansal, Co-Founder and COO of MedVital. "This funding gives us the fuel to scale responsibly, building a system that works not just in ICUs, but in homes and clinics across the country."
Beyond its flagship NPWT device, MedVital has outlined plans to develop liquid chitosan-based dressings for chronic wound management and explore new frontiers in dermal and hair regeneration, effectively bridging the gap between therapeutic and aesthetic medicine.
Investor Confidence in Market Potential
The investment reflects growing confidence in India's medical technology sector, particularly in addressing underserved healthcare needs with locally developed solutions.
"We invest in teams that understand and address India's healthcare challenges on a large scale," said Nihar Parikh, Founder of 4point0 Health Ventures. "MedVital's strategic approach to hard-to-heal wound management and minimally invasive treatments positions them uniquely in the healthcare landscape. Their focus on improving accessibility of high-quality science backed with measurable clinical outcomes addresses exactly what the market demands."
Addressing Critical Healthcare Gaps
MedVital's focus on wound care addresses a significant healthcare challenge in India, where diabetic foot ulcers and other chronic wounds contribute to high amputation rates and healthcare costs. The company's integrated approach aims to improve clinical outcomes while reducing the economic burden of chronic wound management.
With its emphasis on local manufacturing and accessibility, MedVital represents a growing trend of Indian healthcare startups developing solutions specifically designed for domestic healthcare challenges while maintaining global quality standards.
As the company continues to develop its product pipeline and clinical footprint, it positions itself as a potential category-defining player in regenerative medicine—built in India but designed with global impact in mind.
